What Are Clinical Trials for Cancer?

Clinical trials are research studies that evaluate new or existing drugs, devices, or treatment approaches in humans. They are conducted to gather information about the safety and effectiveness of these interventions and to determine whether they are better than the standard of care.

Clinical trials for cancer are designed to evaluate new or existing treatments for cancer, such as new drugs, radiation therapies, surgical techniques, or combinations of these approaches. These trials are conducted in phases, with each phase having specific goals and objectives.

Phase 1 trials are the first studies in humans and are designed to evaluate the safety of a new treatment. These trials typically involve a small number of patients and are conducted to determine the maximum tolerated dose (MTD) of the treatment.

Phase 2 trials are designed to further evaluate the safety and efficacy of a new treatment. These trials typically involve a larger number of patients than Phase 1 trials and are conducted to determine the optimal dose of the treatment and to assess its preliminary efficacy.

Phase 3 trials are large-scale studies that compare a new treatment to the standard of care. These trials are designed to provide definitive evidence about the safety and efficacy of the new treatment.

Phase 4 trials are conducted after a new treatment has been approved by the FDA. These trials are designed to monitor the long-term safety and efficacy of the treatment and to identify any adverse events that may not have been detected during the earlier phases of clinical development.

Clinical trials for cancer offer patients the opportunity to access new and potentially more effective treatments. These trials are essential for advancing cancer research and developing new treatments that can save lives.